52,196 Shares in 908 Devices Inc. (NASDAQ:MASS) Bought by XTX Topco Ltd

XTX Topco Ltd bought a new position in shares of 908 Devices Inc. (NASDAQ:MASS - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 52,196 shares of the company's stock, valued at approximately $115,000. XTX Topco Ltd owned 0.15% of 908 Devices as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the business. Geode Capital Management LLC lifted its stake in shares of 908 Devices by 1.2% in the 3rd quarter. Geode Capital Management LLC now owns 567,788 shares of the company's stock valued at $1,970,000 after acquiring an additional 6,634 shares during the last quarter. State Street Corp grew its stake in shares of 908 Devices by 1.2% in the third quarter. State Street Corp now owns 479,044 shares of the company's stock worth $1,662,000 after acquiring an additional 5,704 shares during the period. Barclays PLC increased its position in 908 Devices by 452.7% during the third quarter. Barclays PLC now owns 46,214 shares of the company's stock valued at $160,000 after acquiring an additional 37,853 shares during the last quarter. Concurrent Investment Advisors LLC purchased a new stake in 908 Devices during the fourth quarter valued at approximately $52,000. Finally, Prudential Financial Inc. purchased a new position in 908 Devices during the fourth quarter valued at approximately $34,000. Institutional investors own 88.06% of the company's stock.

Wall Street Analysts Forecast Growth

Several analysts recently weighed in on the company. Stephens restated an "overweight" rating and set a $6.00 price target on shares of 908 Devices in a report on Wednesday, January 15th. Weiss Ratings restated a "sell (d-)" rating on shares of 908 Devices in a report on Thursday, April 24th. Two research analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, 908 Devices presently has a consensus rating of "Moderate Buy" and a consensus target price of $5.33.

908 Devices Trading Up 4.5 %

Shares of 908 Devices stock traded up $0.24 during trading hours on Friday, hitting $5.60. 302,998 shares of the company were exchanged, compared to its average volume of 983,974. The stock has a market capitalization of $197.85 million, a price-to-earnings ratio of -3.16 and a beta of 0.30. The business has a 50-day moving average of $4.14 and a 200-day moving average of $3.15. 908 Devices Inc. has a 1 year low of $1.81 and a 1 year high of $7.48.

908 Devices Company Profile

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.